logo
Miami-Dade healthcare manager found not guilty at Medicare fraud trial

Miami-Dade healthcare manager found not guilty at Medicare fraud trial

Miami Herald17-06-2025
Two years ago, Kenia Valle Boza's life was upended when prosecutors accused her of conspiring with others to assign falsified codes to medical diagnoses that caused the federal government to pay out millions of dollars for excessive billing.
Valle, a certified professional coder for two Miami-Dade healthcare management companies, was the only defendant named in a conspiracy indictment alleging $12 million in Medicare fraud. Neither doctors who made the diagnoses nor executives who managed Valle went to trial with her.
On Friday, Valle was vindicated when a 12-person federal jury in Miami found her not guilty of conspiracy to commit healthcare and wire fraud, along with three counts of major fraud against the United States. Particularly striking about the verdict was that the jury, after a two-week trial, deliberated for only four hours before acquitting her. U.S. District Judge Kathleen Williams also threw out two wire fraud counts before the jurors began deliberations.
It was a rare trial victory for the defense because federal prosecutors almost always win such cases in South Florida, long recognized as the nation's capital of healthcare fraud.
Valle's defense lawyers, Frank Monsour and Adam Fels, said they were grateful to the jurors for seeing through a criminal case that was based on 'cherry-picked' coding data packaged by prosecutors to make their client look guilty.
'This is not how you prosecute someone in the United States of America,' Monsour told jurors during closing arguments on Friday. 'This is not proof beyond a reasonable doubt. It's offensive. That's what this is. And it permeates this entire case.'
Valle, 41, of West Kendall, worked as a coding manager at Pasteur Medical Center between 2015 and 2017. Pasteur operated several medical clinics in Miami-Dade and Broward counties. After that stint, Valle worked as director of Medicare risk adjustment analytics at HealthSun Health Plans, Inc. until early 2020. HealthSun operated several Medicare Advantage plans serving patients in both counties.
A major part of Valle's job at Pasteur was to ensure that the right codes were assigned to medical diagnoses and procedures for billing to Medicare, the federal insurance program for senior citizens.
The indictment accused Valle of falsely coding several diagnoses, including two particular diagnoses highlighted by prosecutors, to boost Medicare reimbursements by about $12 million. One coding was for 'Other Hemoglobinopathies,' an abnormality in the structure of protein in red blood cells that carry oxygen. The other coding was for 'Disorder of Carbohydrate Metabolism, Unspecified,' a disorder that affects the body's ability to break down carbohydrates.
But at trial, Valle's defense lawyers poked a big hole in the prosecution's case, saying they uncovered data to show that the doctors made those two diagnoses at Pasteur when Valle supervised the coders for billing to Medicare. Moreover, the lawyers said they were able to prove that the codes for risk-adjustment diagnoses generally decreased when Valle managed the coders at Pasteur.
When Valle worked as a Medicare risk-adjustment manager at HealthSun, she was not involved in supervising any healthcare coders, the lawyers said.
They also argued that Valle did not personally benefit from upcoding the diagnoses — that she was paid a 'competitive' salary that ranged from $70,000 to $130,000 over the span of her five years with Pasteur and HealthSun.
Fels told jurors at the outset of the trial that the 'government cannot show any extra money that Kenia received for this alleged fraudulent scheme, not even a dime. ... There are no fancy cars. There are no houses. There are no properties, no bags of cash.
'That's because the evidence is going to show that all Kenia got from working at Pasteur was her hard-earned salary.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

With UnitedHealth Group (UNH) Stock Down Over 50%, Let's Look at Who Owns It
With UnitedHealth Group (UNH) Stock Down Over 50%, Let's Look at Who Owns It

Business Insider

time12 hours ago

  • Business Insider

With UnitedHealth Group (UNH) Stock Down Over 50%, Let's Look at Who Owns It

UnitedHealth Group (UNH) has had a rough ride in 2025. The stock is down over 56% year-to-date, hit by rising medical costs, a DOJ probe, executive changes, and now disappointing Q2 results. The company recently posted adjusted earnings per share of $4.08 on $111.6 billion in revenue, narrowly beating the revenue forecast but missing the EPS consensus of around $4.45. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Still, the company reaffirmed its full-year guidance and provided more clarity on its 2025–2026 outlook, prompting mixed reactions from analysts. For instance, analyst Lance Wilkes from Bernstein remains optimistic, citing UnitedHealth's strong market position and potential rebound in Medicare Advantage trends. In contrast, BofA analyst Kevin Fischbeck is more cautious, due to concerns over the company's slower growth pace. With the stock in focus, now's a good time to take a closer look at who actually owns UNH shares. Now, according to TipRanks' ownership page, public companies and individual investors own 45.60% of UNH. They are followed by mutual funds, ETFs, other institutional investors, and insiders at 28.84%, 23.20%, 2.19%, and 0.18%, respectively. Digging Deeper into UnitedHealth Group's Ownership Structure Looking closely at top shareholders, Vanguard owns the highest stake in UNH at 8.89%. Next up is Vanguard Index Funds, which holds a 7.03% stake in the company. Among the top ETF holders, the Vanguard Total Stock Market ETF (VTI) owns a 3.22% stake in UNH stock, followed by the Vanguard S&P 500 ETF (VOO), with a 2.84% stake. Moving to mutual funds, Vanguard Index Funds holds about 7.03% of UNH. Meanwhile, Fidelity Concord Street Trust owns 1.72% of the company. Is UNH a Good Buy Now? Turning to Wall Street, UNH stock has a Moderate Buy consensus rating based on 18 Buys, three Holds, and two Sells assigned in the last three months. At $321.76, the average UnitedHealth stock price target implies a 28.93% upside potential.

Saquon Barkley among NFL stars who will join President Trump's council on Sports Nutrition
Saquon Barkley among NFL stars who will join President Trump's council on Sports Nutrition

USA Today

time15 hours ago

  • USA Today

Saquon Barkley among NFL stars who will join President Trump's council on Sports Nutrition

Eagles running back Saquon Barkley will join Harrison Butker, Nick Bosa, Tony Romo, and Lawrence Taylor on President Trumps Council on Sports, Fitness, and Nutrition.' Saquon Barkley is a son, a fantastic father, the NFL's Offensive Player of the Year winner, and now a member of President Donald Trump's administration. In a move that will revive a standard from the Reagan, Clinton, and Bush era, Barkley will join Harrison Butker, Nick Bosa, Tony Romo, and Lawrence Taylor on President Trump's Council on Sports, Fitness, and Nutrition.' According to the Washington Post, President Trump on Thursday announced that the presidential fitness test, a hallmark of American physical education programs, will be making a comeback in public schools. The assessment was retired and replaced by a fitness program under the Obama administration. The presidential fitness test was initiated in the 1950s by a council established by President Dwight D. Eisenhower that was directed to improve the physical fitness of American youths, in response to fears they were falling behind their European counterparts when it came to athleticism. The project is an alternative way to get anti-obesity drugs to Medicare and Medicaid patients, after the administration said in April that neither program would cover GLP-1s for weight loss. In doing so, it scrapped a 2024 Biden administration proposal for the programs to start covering GLP-1s for patients with obesity. Several high-profile athletes — all of whom have existing ties to Trump — attended the ceremony and will serve on the President's Council on Sports, Fitness and Nutrition. The attendees included professional golfer Bryson DeChambeau, who will chair the council; controversial National Football League kicker Harrison Butker; World Wrestling Entertainment mainstay Paul 'Triple H' Levesque; golfer Annika Sorenstam; and football Hall of Famer Lawrence Taylor. The Eagles running back wasn't in attendance, but will be joined by golfers Jack Nicklaus, Nelly Korda, and Gary Player (who was also awarded the Medal of Freedom alongside Sorenstam); Tony Romo, Nick Bosa, and Barkley; legendary hockey player Wayne Gretzky; and baseball player Mariano Rivera. The list also includes NFL Commissioner Roger Goodell, whom Trump repeatedly scrutinized during his first presidential term. Barkley was criticized during the off-season for spending time with President Trump on a golf outing prior to the Eagles' ring celebration.

SmartVascular Dx™ Test Elevates Vascular Risk Detection in the Northeast & Partnership with MOMS
SmartVascular Dx™ Test Elevates Vascular Risk Detection in the Northeast & Partnership with MOMS

Business Upturn

time16 hours ago

  • Business Upturn

SmartVascular Dx™ Test Elevates Vascular Risk Detection in the Northeast & Partnership with MOMS

IRVINE, Calif., Aug. 01, 2025 (GLOBE NEWSWIRE) — MorningStar Laboratories, LLC., ('MSL' or 'the Company'), a leading developer of precision diagnostic tests addressing unmet clinical needs, is excited to announce that its SmartVascular Dx™ (SVDx) test, formerly known as the PULS™ Cardiac Test, is now more accessible than ever for patients in the northeastern United States. We are proud to share that we have been included in the Medicare fee schedule, allowing us to offer national Medicare coverage along with our new partnerships with CareSource and HealthPartners. The SmartVascular Dx test provides a significant clinical advantage by accurately detecting vascular inflammation, a crucial factor in assessing cardiovascular risk. In a healthcare landscape increasingly focused on preventive strategies, this test supports early intervention, aligning seamlessly with the commitment to proactive healthcare in the region. We encourage physicians in the northeastern United States to seize this opportunity to offer the SVDx test to their patients. By identifying vascular risks earlier, healthcare providers can implement timely interventions, ultimately saving lives and improving health outcomes. Furthermore, we are excited to announce our partnership with My One Medical Source® (MOMS), and its network of MAPs: Medical Access Points/Providers™, which will facilitate specimen collection opportunities for MorningStar Laboratories' patients across the country. As the 'Connection for the Collection™,' MOMS enhances access to testing by bridging labs like ours with the skilled personnel needed for specimen collection. For more information and to learn how to integrate the SmartVascular Dx test into your practice, please reach out MorningStar Laboratories at 866.299.8998. Join us in our mission to enhance vascular care and improve the health of our communities. About MorningStar Laboratories MorningStar Laboratories ('MSL') is a specialty diagnostics development clinical laboratory company that develops, performs, and distributes unique medical tests combining science, technology, and proprietary analytics which aim to detect high-risk diseases with significant unmet medical needs. MSL's laboratory information systems use data from multiple sources, including proteomics, genetics, metabolic, biochemistry, phenotype, imaging, and a patented algorithm to address the most challenging clinical problems related to endothelial and vascular inflammatory issues. Morningstar Laboratories, a subsidiary of Smart Health Diagnostics Company, is a CLIA-Certified and CAP Accredited laboratory offering comprehensive and customized services in accordance with Good Laboratory Practice (GLP) and Good Manufacturing Practice (GMP) regulations and ISO 15189 standards. To learn more, visit MorningStar Laboratories at Facebook, X (formerly Twitter), and LinkedIn. About My One Medical Source® (MOMs) My One Medical Source® (MOMS) is a SaaS platform connecting labs and other clients with the skilled labor required to perform specimen collections. The MAP: Medical Access Point/Provider™ Network is comprised of both brick-and-mortar draw sites as well as mobile phlebotomy options in all 50 states and Puerto Rico, which serve as collection solutions for the Labs/Clients on the MOMS platform. To learn more, visit Forward-Looking Statements Forward-looking statements in this press release are based on our future expectations, plans prospects, and assumptions regarding matters that are not historical facts, may constitute 'forward-looking statements' within the meaning of The Private Securities Litigation Reform Act of 1995. The words 'termed,' 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'plan,' 'potential,' 'predict,' 'project,' 'should,' 'target,' 'will,' 'would' and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. Therefore, we caution you against relying on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Any forward-looking statement made by us in this document speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments, or otherwise, except as may be required by law. Media Contact [email protected] 866.299.8998 Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store